Suresh S. Ramalingam, MD, Appointed Executive Director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University

Savolitinib Approved in China for MET-Positive NSCLC

Durvalumab Plus Chemotherapy Approved in China as First-Line Management of Extensive-stage SCLC

First Comprehensive Genomic Profiling Assay Approved for Use with Brigatinib, ALK-positive NSCLC

Selpercatinib Approved in Canada for Metastatic NSCLC with RET Fusions

Sotorasib Wins Approval for Unmet Need in KRAS G12C-Driven NSCLC

Wally Curran Departs Directorship at Emory for a Lead Role with GenesisCare

Dr. Anne-Marie Dingemans Leads EORTC’s Lung Cancer Group

Dr. Marina Garassino Accepts Professorship at University of Chicago

The IASLC Mourns the Loss of Dr. Gouri Bhattacharyya

Christian Rolfo to Move to Mount Sinai

The IASLC Mourns the Loss of Dr. Pierre Massion